Dr. Falk Pharma GmbH | WebDisclosure

Basculer en Français

10916	Companies
238184	Keywords
167066	Articles
127986	Press releases

Home
Companies
Dr. Falk Pharma GmbH

BRIEF

published on 10/29/2024 at 13:05, 1 year 10 months ago

Dr. Falk Pharma Acquires Kynos Therapeutics, Enhancing Portfolio in Inflammatory Diseases

Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
BRIEF

published on 10/29/2024 at 13:05, 1 year 10 months ago

Dr. Falk Pharma acquiert Kynos Therapeutics, enrichissant ainsi son portefeuille dans le domaine des maladies inflammatoires

Maladies Inflammatoires Dr. Falk Pharma KNS366 Thérapeutique Kynos Pancréatite Aiguë
PRESS RELEASE

published on 10/29/2024 at 13:00, 1 year 10 months ago

Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio
Dr. Falk Pharma GmbH acquires Kynos Therapeutics Ltd., focusing on inflammatory disease treatments. KNS366, a novel enzyme inhibitor, shows promise in clinical trials for acute pancreatitis

Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366

Accesswire

Published on 09/02/2026 at 15:00, 3 hours 37 minutes ago

Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia
Published on 09/02/2026 at 14:30, 4 hours 7 minutes ago

Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Published on 09/02/2026 at 14:00, 4 hours 37 minutes ago

Orogen Royalties Acquires Two Gold Projects in Southwest Utah
Published on 09/02/2026 at 14:00, 4 hours 37 minutes ago

Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing
Published on 09/02/2026 at 13:00, 5 hours 37 minutes ago

Snipp-Powered Loyalty Programs Earn Two Gold Awards at Loyalty360 Awards

View all ACCESSWIRE

EQS Group

Published on 09/02/2026 at 18:15, 22 minutes ago

Haier Smart Home Co., Ltd. Launches Voluntary Public Share Buy-back Offer for up to 81,044,512 D-Shares at EUR 1.87
Published on 09/02/2026 at 18:14, 22 minutes ago

Delivery Hero’s Management Board and Supervisory Board publish joint reasoned statement recommending shareholders to accept the takeover offer from Uber
Published on 09/02/2026 at 17:48, 49 minutes ago

FIGEAC AÉRO: CHIFFRE D’AFFAIRES T1 2026/27
Published on 09/02/2026 at 17:48, 49 minutes ago

FIGEAC AÉRO: Q1 2026/27 REVENUE
Published on 09/02/2026 at 17:45, 52 minutes ago

FP Markets: Global bond market alarm bells are ringing

Les Echos

Published on 09/02/2026 at 18:20, 17 minutes ago

Appointment to Edenred’s Executive Committee
Published on 09/02/2026 at 18:20, 17 minutes ago

Nomination au Comité exécutif d'Edenred
Published on 09/02/2026 at 18:00, 37 minutes ago

Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 août 2026
Published on 09/02/2026 at 18:00, 37 minutes ago

Outstanding shares and voting rights statement at 31 August 2026
Published on 09/02/2026 at 17:45, 52 minutes ago

Disclosure of shares outstanding and voting rights - 02.09.2026

View all LES ECHOS COMFI WIRE